东兴医药生物量化选股混合C(020831)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
83,832.17 |
1,972,699.41 |
1,076,664.41 |
2,016,984.37 |
| 利息合计 |
130.01 |
397.80 |
234.48 |
186,679.99 |
| 其中：存款利息收入 |
130.01 |
397.80 |
234.48 |
33,824.00 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
152,855.99 |
| 投资收益合计 |
115,707.31 |
1,436,533.31 |
291,088.11 |
2,360,465.39 |
| 其中：股票投资收益 |
50,302.00 |
1,313,251.13 |
201,122.61 |
2,143,063.05 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
2,071.86 |
5,408.44 |
4,353.57 |
127,574.30 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
63,333.45 |
117,873.74 |
85,611.93 |
89,828.04 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-40,665.26 |
501,084.90 |
772,794.69 |
-555,617.24 |
| 其他收入 |
8,660.11 |
34,683.40 |
12,547.13 |
25,456.23 |
| 费用 |
41,099.39 |
156,458.42 |
99,122.66 |
744,406.64 |
| 管理人报酬 |
30,561.47 |
81,872.86 |
52,529.74 |
436,452.06 |
| 基金托管费 |
5,093.60 |
13,645.58 |
8,755.00 |
72,742.00 |
| 销售服务费 |
5,365.86 |
17,854.98 |
11,703.82 |
139,787.30 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
75.00 |
43,085.00 |
26,134.10 |
94,875.00 |
| 利润总额 |
42,732.78 |
1,816,240.99 |
977,541.75 |
1,272,577.73 |
微信公众号
证券之星APP
基本资料
